The 18th Annual Diabetes Symposium is a 1-day virtual course. The purpose of this symposium is to update health care providers with state-of-the-art information regarding evaluation and treatment of patients with diabetes. There is a need to better understand evolving practice trends in this patient population. Physicians should demonstrate competence in identifying optimal therapeutic interventions to prevent the cardiovascular and renal complications of diabetes as per the guidelines published by the ADA. In addition, they should understand the use of SGLT2 inhibitors in patients with diabetes and heart failure. Furthermore, they should understand newer strategies for weight loss in obese patients. Physicians should also understand the management of diabetes in hospitalized patients including the use of continuous glucose monitors. In addition, they should be able to apply new diabetes technology for insulin delivery and understand the advantages (e.g. reduction in hypoglycemia) with newer technology and insulin formulations. Physicians should effectively identify the adverse effects of diabetes therapies and identify additional practice gaps that should be addressed in the future.
- Provider:Texas Heart Institute
- Activity Link: https://www.texasheart.org/education/continuing-medical-education/our-symposia/18th-annual-diabetes-symposium/
- Start Date: 2025-06-28 05:00:00
- End Date: 2025-06-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 8.75 hours
- MOC Credit Details: ABIM - 8.75 Point; Credit Type(s): Medical Knowledge (ABIM)
ABIM - 8.75 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: No
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Cardiovascular Disease, Endocrinology, Diabetes, and Metabolism